Report cover image

Europe BioPhotonics Market Size, Share & Industry Analysis Report By Technology (In-Vitro, and In-Vivo), By End Use, By Application, By Country and Growth Forecast, 2025 - 2032

Publisher Knowledge Based Value (KBV) Research
Published May 20, 2025
Length 168 Pages
SKU # KBV20068034

Description

The Europe BioPhotonics Market would witness market growth of 9.8% CAGR during the forecast period (2025-2032).

The Germany market dominated the Europe BioPhotonics Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $9,040 million by 2032, growing at a CAGR of 8.3 % during the forecast period. The UK market is exhibiting a CAGR of 8.6% during (2025 - 2032). Additionally, The France market would experience a CAGR of 10.7% during (2025 - 2032).

Integration with artificial intelligence and machine learning algorithms is enhancing the interpretability of complex datasets, fostering smarter diagnostic platforms and real-time decision-making in clinical settings. Miniaturization of photonic devices and progress in lab-on-a-chip technologies are further accelerating point-of-care applications, promoting decentralized and rapid diagnostics even in resource-limited environments.

The increasing adoption of personalized medicine has bolstered demand for biophotonic tools, which allow detailed cellular profiling and real-time patient monitoring. In therapeutics, light-activated treatment techniques such as photodynamic therapy are being refined for greater efficacy and specificity, offering alternatives to conventional methods in areas like oncology and dermatology.

The BioPhotonics Market in Europe is evolving rapidly, underpinned by strong institutional research, government-backed healthcare modernization, and a growing demand for non-invasive diagnostic technologies. European countries such as Germany, France, the UK, and the Netherlands are investing heavily in photonics-enabled life sciences, with EU-wide initiatives like Photonics21 and Horizon Europe fostering collaborative R&D in optical imaging, biosensing, and phototherapy. The adoption of BioPhotonics is also being supported by Europe’s emphasis on personalized medicine and the digitization of healthcare. Hospitals and research centers are increasingly using real-time imaging and photonic diagnostics for tailored treatment planning, particularly in cancer care and vascular disease. In terms of competition, Europe is home to both established players like Carl Zeiss Meditec, B&W Tek, and Horiba Europe, and a rising wave of photonics-focused startups. Thus, Europe’s BioPhotonics market is positioned for sustained innovation and growth, fueled by robust public-private partnerships and a strong commitment to precision and preventive healthcare.

Based on Technology, the market is segmented into In-Vitro, and In-Vivo. Based on End Use, the market is segmented into Medical Diagnostics, Tests & Components, Medical Therapeutics, and Non-medical Application. Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, and Biosensors & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Oxford Instruments plc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • IPG Photonics Corporation
  • Lumenis Be Ltd.
  • Becton, Dickinson and Company
  • Shimadzu Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
Europe BioPhotonics Market Report Segmentation

By Technology
  • In-Vitro
  • In-Vivo
By End Use
  • Medical Diagnostics
  • Tests & Components
  • Medical Therapeutics
  • Non-medical Application
By Application
  • See-Through imaging
  • Microscopy
  • Inside Imaging
  • Spectro Molecular
  • Analytics Sensing
  • Light Therapy
  • Surface Imaging
  • Biosensors & Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

168 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe BioPhotonics Market, by Technology
1.4.2 Europe BioPhotonics Market, by End Use
1.4.3 Europe BioPhotonics Market, by Application
1.4.4 Europe BioPhotonics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2024
4.2 Porter Five Forces Analysis
Chapter 5. Key Customer Criteria in the BioPhotonics Market
5.1 Accuracy and Sensitivity
5.2 Non-Invasiveness and Patient Safety
5.3 Portability and Ease of Integration
5.4 Speed and Real-Time Capabilities
5.5 Regulatory Approvals and Compliance
5.6 Cost-Effectiveness and ROI
5.7 Customizability and Application Flexibility
5.8 Technical Support and Training
5.9 Data Handling and Software Integration
5.10. Brand Reputation and Clinical Validation
Chapter 6. Europe BioPhotonics Market by Technology
6.1 Europe In-Vitro Market by Country
6.2 Europe In-Vivo Market by Country
Chapter 7. Europe BioPhotonics Market by End Use
7.1 Europe Medical Diagnostics Market by Country
7.2 Europe Tests & Components Market by Country
7.3 Europe Medical Therapeutics Market by Country
7.4 Europe Non-medical Application Market by Country
Chapter 8. Europe BioPhotonics Market by Application
8.1 Europe See-Through imaging Market by Country
8.2 Europe Microscopy Market by Country
8.3 Europe Inside Imaging Market by Country
8.4 Europe Spectro Molecular Market by Country
8.5 Europe Analytics Sensing Market by Country
8.6 Europe Light Therapy Market by Country
8.7 Europe Surface Imaging Market by Country
8.8 Europe Biosensors & Others Market by Country
Chapter 9. Europe BioPhotonics Market by Country
9.1 Germany BioPhotonics Market
9.1.1 Germany BioPhotonics Market by Technology
9.1.2 Germany BioPhotonics Market by End Use
9.1.3 Germany BioPhotonics Market by Application
9.2 UK BioPhotonics Market
9.2.1 UK BioPhotonics Market by Technology
9.2.2 UK BioPhotonics Market by End Use
9.2.3 UK BioPhotonics Market by Application
9.3 France BioPhotonics Market
9.3.1 France BioPhotonics Market by Technology
9.3.2 France BioPhotonics Market by End Use
9.3.3 France BioPhotonics Market by Application
9.4 Russia BioPhotonics Market
9.4.1 Russia BioPhotonics Market by Technology
9.4.2 Russia BioPhotonics Market by End Use
9.4.3 Russia BioPhotonics Market by Application
9.5 Spain BioPhotonics Market
9.5.1 Spain BioPhotonics Market by Technology
9.5.2 Spain BioPhotonics Market by End Use
9.5.3 Spain BioPhotonics Market by Application
9.6 Italy BioPhotonics Market
9.6.1 Italy BioPhotonics Market by Technology
9.6.2 Italy BioPhotonics Market by End Use
9.6.3 Italy BioPhotonics Market by Application
9.7 Rest of Europe BioPhotonics Market
9.7.1 Rest of Europe BioPhotonics Market by Technology
9.7.2 Rest of Europe BioPhotonics Market by End Use
9.7.3 Rest of Europe BioPhotonics Market by Application
Chapter 10. Company Profiles
10.1 Oxford Instruments plc
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Bio-Rad laboratories, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 SWOT Analysis
10.4 IPG Photonics Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.5 Lumenis Be Ltd.
10.5.1 Company Overview
10.5.2 SWOT Analysis
10.6 Becton, Dickinson, and Company
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 SWOT Analysis
10.7 Shimadzu Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 SWOT Analysis
10.8 Carl Zeiss AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Olympus Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 SWOT Analysis
10.10. Hamamatsu Photonics K.K.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us